Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimicet-M 2 Tablet PR

Prescription Icon
Prescription Required

Marketer

Affix Pharmaceuticals Pvt. Ltd.

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimicet-M 2 Tablet PR

DiaBeta-Duo 2mg tablets are classified as anti-diabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This formulation assists in regulating blood glucose. DiaBeta-Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry readily-available glucose, such as sugary snacks or juice. Alcohol increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women must consult their doctor. Regular blood glucose monitoring, along with potential blood tests for blood cell counts and liver function, are recommended.

Uses of Glimicet-M 2 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimicet-M 2 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Administer Glimicet-M 2 Tablet PR with a meal.

Common Side effects of Glimicet-M 2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimicet-M 2 Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take Glimicet-M 2 Tablet PR with a meal.

How Glimicet-M 2 Tablet PR works:

Glimicet-M 2 Tablet PR combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, inhibiting intestinal glucose uptake, and enhancing insulin responsiveness in peripheral tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimicet-M 2 Tablet PR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimicet-M 2 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with a doctor is advised.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated for patients using Glimicet-M 2 Tablet PR due to potential infant toxicity indicated by available data.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimicet-M 2 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimicet-M 2 Tablet PR is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimicet-M 2 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is typically recommended for those with mild to moderate liver disease; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimicet-M 2 Tablet PR :

Should you forget a Glimicet-M 2 Tablet PR dose, take it immediately if you remember. However, near the time for your next dose, omit the missed one and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Glimicet-M 2 Tablet PR

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Glimicet-M 2 Tablet PR

Securely store this medication in its original, tightly sealed container or packaging. Follow the storage guidelines provided on the label or packaging. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Indeed, Glimicet-M 2 Tablet PR can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this infrequent adverse reaction to metformin poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Manifestations of lactic acidosis might encompass myalgia or weakness, vertigo, fatigue, acral coldness, dyspnea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Glimicet-M 2 Tablet PR and seek immediate medical attention.
Duo-Met 2 Tablet PR, a dual-action formulation containing glimepiride and metformin, manages type 2 diabetes mellitus (DM) in adults. This medication enhances glycemic control when coupled with a balanced diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin's action involves decreasing hepatic glucose production and improving cellular insulin responsiveness. This combination therapy is unsuitable for type 1 DM.
Glimicet-M 2 Tablet PR may cause common adverse reactions including low blood glucose, taste disturbances, nausea, abdominal discomfort, loose stools, and cephalalgia. Rare but potentially severe reactions such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 insufficiency.
Prolonged Glimicet-M 2 Tablet PR administration can indeed lead to Vitamin B12 deficiency due to impaired intestinal Vitamin B12 absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as peripheral neuropathy (manifested by tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and ataxia. Preventive measures, as proposed by some studies, include annual supplemental Vitamin B12 intake.
Indeed, Glimicet-M 2 Tablet PR can induce hypoglycemia, characterized by low blood glucose. Manifestations of this condition encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available source of glucose, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimicet-M 2 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). This combination also raises the likelihood of lactic acidosis.
Glimicet-M 2 Tablet PR
82
MRP 100
18% off